Clin2
NCT07356765Possibly a fitEnrolling by invitation

Berberine for negative symptoms of schizophrenia

SchizophreniaNegative Symptoms of Schizophrenia

Treatments studied

Part of Mental health clinical trials.

This trial tests if berberine, a natural supplement, can help reduce negative symptoms like lack of motivation or social withdrawal in people with schizophrenia. It may work by affecting the brain and body.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old
  • You have a confirmed diagnosis of schizophrenia
  • You are of Han Chinese ethnicity
  • You have been taking the same antipsychotic medication for at least 3 months
  • You have significant negative symptoms (like low motivation or reduced speech)
  • You are not pregnant or breastfeeding, and do not have certain health conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07393464Not yet recruiting
PQQ for cognitive and negative symptoms in schizophrenia

This trial tests if a supplement called PQQ can help with cognitive problems and negative symptoms (like lack of motivation) in people with schizophrenia. It may offer a new way to support current treatment.

NCT04226898Recruiting· Phase 2
Synbiotic supplement to lessen schizophrenia symptoms

This Phase 2 trial tests whether a “synbiotic” supplement (a mix of probiotics and prebiotics) can reduce symptoms of schizophrenia or schizoaffective disorder. It may help by targeting gut-related immune and inflammation pathways that could affect brain symptoms.

Batlimore, Maryland
NCT07565428Recruiting· Phase 3
Study of roluperidone for negative symptoms of schizophrenia

This trial tests a new medicine called roluperidone for people with schizophrenia who have ongoing negative symptoms (like low motivation or social withdrawal) but stable positive symptoms (like hallucinations). It aims to see if the drug helps with these symptoms and if it can reduce the chance of relapse compared to other medications.

Bellflower, California
NCT06642675Recruiting
Brain stimulation for negative symptoms in schizophrenia

This trial tests whether a non-invasive brain stimulation technique called nTMS (repetitive transcranial magnetic stimulation) can help reduce negative symptoms of schizophrenia, like lack of motivation or social withdrawal. It's a possible treatment option for people with stable schizophrenia who still struggle with these symptoms.

Changsha, Hunan
NCT07122895Recruiting· Phase 2
NMDA enhancer for negative symptoms in schizophrenia

This study tests whether a medication that boosts brain NMDA receptors can improve negative symptoms in schizophrenia, and looks at differences between men and women. It is for people with stable schizophrenia who still have mostly flat mood or low motivation.

Taichung
NCT06340789Recruiting· Phase 2
Sodium Benzoate Added to Antipsychotics for Resistant Schizophrenia

This study tests whether adding a supplement called sodium benzoate to your current antipsychotic medication can improve symptoms in schizophrenia that hasn't responded well to standard treatments. Researchers will measure brain chemistry changes and symptom improvement over time.

Chiayi City

Hear when a new Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.